pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
CASIN
Ageing
Mogling Bio Inc
0
catalysts
CATAPRES-TTS-1
CATAPRES-TTS-1 (CLONIDINE TRANSDERMAL SYSTEM)
LAVIPHARM
0
catalysts
Phase 1
CB-011
Refractory Multiple Myeloma
DNA-directed RNA polymerase
$CRBU
Caribou Biosciences, Inc.
0
catalysts
Phase 3
← prev
page 67 of 231
next →
131
Pain
89
Neurology
1
CB-03154
Amyotrophic Lateral Sclerosis
Shanghai Zhimeng Biopharma Inc
0
catalysts
Phase 1
CB-06036
Hepatitis B
$GSK
GSK plc
0
catalysts
Phase 1
CB-11
Glioblastoma Multiforme (GBM)
Cellebrain Co Ltd
0
catalysts
Preclinical
CB-303
Solid Tumor
CentricsBio Inc
0
catalysts
Phase 1
CBI-1214
Metastatic Colorectal Cancer
Cartography Biosciences Inc
0
catalysts
Phase 2
CBL-514
Adiposis Dolorosa (Dercum's Disease or Anders Disease)
Caliway Biopharmaceutics Co Ltd
0
catalysts
Preclinical
CBM-301
Idiopathic Pulmonary Fibrosis
CellionBioMed Inc
0
catalysts
Phase 2
CBP-1019
Breast Cancer
Coherent Biopharma
0
catalysts
Phase 1
CBP-4888
Pre-Eclampsia
Comanche Biopharma Corp
0
catalysts
Phase 2
CBP-501
Pancreatic Cancer
CanBas Co Ltd
0
catalysts
Preclinical
CBP/p300 Inhibitors
Central Nervous System (CNS) Cancer
Sumitomo Pharma Co Ltd
0
catalysts
Preclinical
CBS-101
Retinitis Pigmentosa (Retinitis)
CIRC Biosciences Inc
0
catalysts
Phase 2
CBT-004
Unspecified Ophthalmological Disorders
Cloudbreak Therapeutics LLC
0
catalysts
Phase 2
CBT-006
Keratoconjunctivitis Sicca (Dry Eye)
Cloudbreak Therapeutics LLC
0
catalysts
Preclinical
CBT-007
Glaucoma
Cloudbreak Therapeutics LLC
0
catalysts
Preclinical
CBT-145
Presbyopia
Cloudbreak Therapeutics LLC
0
catalysts
Phase 2
CBX-12
Colorectal Cancer
Cybrexa Inc
0
catalysts
Preclinical
CC-2401
Solid Tumor
CytoCan Corp
0
catalysts
Preclinical
CC-2402
Solid Tumor
CytoCan Corp
0
catalysts
Phase 1
CC-8464
Erythromelalgia
$PTHS
Pelthos Therapeutics Inc.
0
catalysts
Phase 1
CCAR-066
Diffuse Large B-Cell Lymphoma
Janssen Biotech Inc
0
catalysts
Phase 1
CD38-SADA
B-Cell Non-Hodgkin Lymphoma
Y-mAbs Therapeutics Inc
0
catalysts
Phase 1
CD4LVFOXP3
Unspecified Genetic Disorders
Stanford University
0
catalysts
Preclinical
CD6/CTLA4 CAR-Treg-Dermatological Basket
Psoriasis
Immuthera Inc
0
catalysts
Preclinical
CD6/CTLA4 CAR-Treg-Neuro Basket
Amyotrophic Lateral Sclerosis
Immuthera Inc
0
catalysts
Phase 2
CDI-988
Norovirus Infections
$COCP
Cocrystal Pharma, Inc.
0
catalysts
Preclinical
CDKN2A Program
Pancreatic Cancer
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
